US Marketers Exploiting Growing Probiotics Demand Warned About Disease, Anxiety Claims
Executive Summary
FDA warnings indicate marketers are looking to take advantage of growing demand for probiotics with disease treatment claims and also pitching herbal remedies to consumers to alleviate anxiety, depression and insomnia. New York firm offers OTC sales of injectable serums for skin toning.
You may also be interested in...
Kyowa Hakko’s Immuse Paraprobiotic Works In Small Intestine For Immune Support
Kyowa Hakka offers Immuse paraprobiotic to activate the plasmacytoid dendritic cells in small intestine while most other probiotics work in large intestine. GOLO's Go-Digest supplement promotes healthy microflora in gut to support overall health.
COVID-19 Test Kit’s Use Of US FDA Logo With ‘Clinical Trial Number’ Fails Regulatory Test
Anytime COVID Test marketed home-use test without FDA approval or EUA and promoted it with an FDA logo and a “clinical trial number.” Warning letter says “your presentation conveys the misimpression that the product has been approved, cleared, authorized, endorsed or otherwise evaluated by FDA.”
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.